I read with great interest the literature review proposed by Kim SY and colleagues in the Journal issue dedicated to the role of HDL as potential disease biomarkers and therapeutic targets in systemic lupus erythematosus (SLE) (1) and felt that the part dedicated to anti-apoA-I autoantibodies would certainly benefit from the following comments.

中文翻译：

---

系统性红斑狼疮中的抗载脂蛋白AI：金等人的文章评论。

我非常有兴趣地阅读了Kim SY及其同事在《华尔街日报》上提出的文献综述，内容涉及HDL在系统性红斑狼疮（SLE）中作为潜在疾病生物标志物和治疗靶标的作用（1），并认为该部分专门针对抗apoA-I自身抗体肯定会从以下评论中受益。